Interleukin-2 and Lanreotide in the Treatment of Medullary Thyroid Cancer: In Vitro and In Vivo Studies

Giovanni Vitale; Giovanni Lupoli; Rosario Guarrasi; Annamaria Colao; Alessandra Dicitore; Germano Gaudenzi; Gabriella Misso; Maria Castellano; Raffaele Addeo; Gaetano Facchini; Salvatore Del Prete; Michele Caraglia

首页> 外文期刊>The journal of clinical endocrinology and metabolism >Interleukin-2 and Lanreotide in the Treatment of Medullary Thyroid Cancer: In Vitro and In Vivo Studies

【24h】

Interleukin-2 and Lanreotide in the Treatment of Medullary Thyroid Cancer: In Vitro and In Vivo Studies

机译：IL-2和Lanreotide在治疗髓样甲状腺癌中的体内和体外研究

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Context:To date no efficacious treatments are available for advanced medullary thyroid carcinoma (MTC).

机译：背景：迄今为止，尚无有效的治疗晚期甲状腺髓样癌（MTC）的方法。

著录项

来源
《The journal of clinical endocrinology and metabolism》 |2013年第10期|共8页
作者
Giovanni Vitale; Giovanni Lupoli; Rosario Guarrasi; Annamaria Colao; Alessandra Dicitore; Germano Gaudenzi; Gabriella Misso; Maria Castellano; Raffaele Addeo; Gaetano Facchini; Salvatore Del Prete; Michele Caraglia;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Value of 111In-DOTA-lanreotide and 111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer: results of in vitro binding studies and in vivo comparison with 18F-FDG PET. [J] . Rodrigues M, Traub Weidinger T, Leimer M, European Journal of Nuclear Medicine and Molecular Imaging . 2005,第10期

机译：111In-DOTA-兰瑞肽和111In-DOTA-DPhe1-Tyr3-奥曲肽在分化型甲状腺癌中的价值：体外结合研究的结果以及与18F-FDG PET的体内比较。
2. CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo [J] . AntonelliA., BocciG., LaMottaC., Molecular and Cellular Endocrinology . 2014,第1a2期

机译：CLM29是一种多靶位吡唑并嘧啶衍生物，在甲状腺髓样癌的体内和体外具有抗肿瘤活性
3. In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer [J] . BentzienF., ZuzowM., HealdN., Thyroid: official journal of the American Thyroid Association . 2013,第12期

机译：甲状腺髓样癌模型中卡波替尼（XL184）（RET，MET和VEGFR2的抑制剂）的体外和体内活性
4. Photoacoustic analysis of thyroid cancer in vivo: A pilot study [C] . Jeesu Kim, Min-Hee Kim, Kwanhoon Jo, Conference on photons plus ultrasound: imaging and sensing . 2017

机译：体内甲状腺癌的光声分析：一项初步研究
5. Preparation and in Vitro, in Vivo Evaluation of 5-Fluorouracil Using Novel Delivery Systems of Colorectal Cancer Treatment [D] . Smith, Taylor A. 2020

机译：制备和体外，体内评价5-氟尿嘧啶，使用结直肠癌治疗新型递送系统
6. Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results [O] . M Raderer, G Hamilton, A Kurtaran, 1999

机译：长效生长抑素类似物兰瑞肽治疗晚期胰腺癌的体内外结果
7. Interleukin-2 and lanreotide in the treatment medullary thyroid cancer:in vitro and in vivo studies [O] . Vitale G, Lupoli G, Guarrasi R, 2013

机译：白细胞介素-2和兰瑞肽在甲状腺髓样癌治疗中的应用：体外和体内研究

相关主题

Interleukin-2 and Lanreotide in the Treatment of Medullary Thyroid Cancer: In Vitro and In Vivo Studies

摘要

著录项

相似文献

相关主题

期刊订阅